Cite
MLA Citation
Alberto Chiappori et al.. “P860 Results from a combination of OX40 (PF-04518600) and 4–1BB (utomilumab) agonistic antibodies in melanoma and non-small cell lung cancer in a phase 1 dose expansion cohort.” Journal for immunotherapy of cancer, vol. 8, n.d., pp. A9–A10. http://access.bl.uk/ark:/81055/vdc_100135176490.0x000005